Our new oncology patent WO2022180080 was approved and is already available in the WIPO database. The patent protects a new generation of antitumor agents with…
cancer
A study led by First Health Pharmaceuticals B.V. (FHPBV) and the Italian Institute of oncological research and prevention (ISPRO), together with the University of Siena…
First Health Pharmaceuticals will participate in the workshop organized by Oncode Institute dedicated to glioblastoma. The workshop will be held on October 16th 2019, in…
First Health Pharmaceuticals is thrilled to announce its latest collaboration on cancer research with an Oncode Institute-affiliate. Oncode is an independent Dutch research institute established…
First Health Pharmaceuticals and First Health United Foundation are going to participate at AIDS2018, the 22nd International AIDS Conference on HIV and AIDS, which will take…
The latest results of a wide range of cell culture assays of some of our compounds against triple negative metastatic breast cancer, metastatic (smokers) lung…
Our research clearly points towards an important role of DDX3 overexpression in cancer. We have already had very positive test results in breast cancer but…